Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Other Issues:
Previous Next
  [Index by Author]
 
Contents: Volume 26, Issue 7
March 1, 2008
 

Down CELEBRATING 25 YEARS OF JCO
  Down Commentary
Down EDITORIALS
Down COMMENTS AND CONTROVERSIES
Down ORIGINAL REPORTS
  Down Cost Effectiveness
  Down Supportive Care and Quality of Life
  Down Breast Cancer
  Down Clinical Practice
  Down Gastrointestinal Cancer
  Down Genetic Testing for Cancer
  Down Hematologic Malignancies
  Down Pediatric Oncology
  Down Phase I and Clinical Pharmacology
  Down Thoracic Oncology
Down REVIEW ARTICLE
Down SPECIAL ARTICLES
Down DIAGNOSIS IN ONCOLOGY
Down ART OF ONCOLOGY
Down CORRESPONDENCE
Down ERRATA

Find articles in this issue containing these words:
[Search ALL Issues]


Table of Contents (PDF) | Editorial Board (PDF) | Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

 
CELEBRATING 25 YEARS OF JCO Back

Commentary Back

Tailoring Treatment to Prognosis for Childhood Localized Non-Hodgkin's Lymphoma
Sharon B. Murphy
JCO Mar 1 2008: 1020–1021. [Full Text] [PDF] [From JCO 1983]  
 
EDITORIALS Back
Is Anemia of Cancer Different From Chemotherapy-Induced Anemia?
David P. Steensma
JCO Mar 1 2008: 1022–1024. First published on Jan 28 2008; 10.1200/JCO.2007.15.3874. [Full Text] [PDF]  
A for Effort: Learning From the Application of the GRADE Approach to Cancer Guideline Development
Melissa C. Brouwers, Mark R. Somerfield, and George P. Browman
JCO Mar 1 2008: 1025–1026. [Full Text] [PDF]  
 
COMMENTS AND CONTROVERSIES Back
Including Persons With HIV Infection in Cancer Clinical Trials
Govind C. Persad, Richard F. Little, and Christine Grady
JCO Mar 1 2008: 1027–1032. [Full Text] [PDF] [Publisher's Note]  
 
ORIGINAL REPORTS Back

Cost Effectiveness Back

Developing Clinical Recommendations for Breast, Colorectal, and Lung Cancer Adjuvant Treatments Using the GRADE System: A Study From the Programma Ricerca e Innovazione Emilia Romagna Oncology Research Group
  Rossana De Palma, Alessandro Liberati, Giovannino Ciccone, Elena Bandieri, Maurizio Belfiglio, Manuela Ceccarelli, Maurizio Leoni, Giuseppe Longo, Nicola Magrini, Maurizio Marangolo, and Fausto Roila
  JCO Mar 1 2008: 1033–1039. [Abstract] [Full Text] [PDF]  

Supportive Care and Quality of Life Back

Darbepoetin Alfa for the Treatment of Anemia in Patients With Active Cancer Not Receiving Chemotherapy or Radiotherapy: Results of a Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
  Robert E. Smith, Jr, Matti S. Aapro, Heinz Ludwig, Tamás Pintér, Martin Smakal, Tudor E. Ciuleanu, Li Chen, Tom Lillie, and John A. Glaspy
  JCO Mar 1 2008: 1040–1050. First published on Jan 28 2008; 10.1200/JCO.2007.14.2885. [Abstract] [Full Text] [PDF] [Chinese PDF] [German PDF] [Publisher's Note]  

Breast Cancer Back

Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230
  Richard Eastell, Judith E. Adams, Robert E. Coleman, Anthony Howell, Rosemary A. Hannon, Jack Cuzick, John R. Mackey, Matthias W. Beckmann, and Glen Clack
  JCO Mar 1 2008: 1051–1057. [Abstract] [Full Text] [PDF]  
Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial
  Mitch Dowsett, Craig Allred, Jill Knox, Emma Quinn, Janine Salter, Chris Wale, Jack Cuzick, Joan Houghton, Norman Williams, Elizabeth Mallon, Hugh Bishop, Ian Ellis, Denis Larsimont, Hironobu Sasano, Pauline Carder, Antonio Llombart Cussac, Fiona Knox, Valerie Speirs, John Forbes, and Aman Buzdar
  JCO Mar 1 2008: 1059–1065. First published on Jan 28 2008; 10.1200/JCO.2007.12.9437. [Abstract] [Full Text] [PDF] [German PDF]  
Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy
  Stephen Johnston, Maureen Trudeau, Bella Kaufman, Hamouda Boussen, Kimberley Blackwell, Patricia LoRusso, Donald P. Lombardi, Slim Ben Ahmed, Dennis L. Citrin, Michelle L. DeSilvio, Jennifer Harris, Ron E. Westlund, Vanessa Salazar, Tal Z. Zaks, and Neil L. Spector
  JCO Mar 1 2008: 1066–1072. First published on Jan 22 2008; 10.1200/JCO.2007.13.9949. [Abstract] [Full Text] [PDF]  

Clinical Practice Back

Preventive Care for Colorectal Cancer Survivors: A 5-Year Longitudinal Study
  Claire F. Snyder, Craig C. Earle, Robert J. Herbert, Bridget A. Neville, Amanda L. Blackford, and Kevin D. Frick
  JCO Mar 1 2008: 1073–1079. [Abstract] [Full Text] [PDF]  

Gastrointestinal Cancer Back

Concomitant Administration of Weekly Oxaliplatin, Fluorouracil Continuous Infusion, and Radiotherapy After 2 Months of Gemcitabine and Oxaliplatin Induction in Patients With Locally Advanced Pancreatic Cancer: A Groupe Coordinateur Multidisciplinaire en Oncologie Phase II Study
  Laurence Moureau-Zabotto, Jean-Marc Phélip, Pauline Afchain, Laurent Mineur, Thierry André, Veronique Vendrely, Gerard Lledo, Olivier Dupuis, Florence Huguet, Emmanuel Touboul, Jacques Balosso, and Christophe Louvet
  JCO Mar 1 2008: 1080–1085. [Abstract] [Full Text] [PDF] [German PDF]  
Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781
  Joel Tepper, Mark J. Krasna, Donna Niedzwiecki, Donna Hollis, Carolyn E. Reed, Richard Goldberg, Krystyna Kiel, Christopher Willett, David Sugarbaker, and Robert Mayer
  JCO Mar 1 2008: 1086–1092. [Abstract] [Full Text] [PDF] [Russian PDF] [Chinese PDF]  

Genetic Testing for Cancer Back

Predictors of Contralateral Prophylactic Mastectomy in Women With a BRCA1 or BRCA2 Mutation: The Hereditary Breast Cancer Clinical Study Group
  Kelly A. Metcalfe, Jan Lubinski, Parviz Ghadirian, Henry Lynch, Charmaine Kim-Sing, Eitan Friedman, William D. Foulkes, Susan Domchek, Peter Ainsworth, Claudine Isaacs, Nadine Tung, Jacek Gronwald, Shelly Cummings, Teresa Wagner, Siranoush Manoukian, Pål Møller, Jeffrey Weitzel, Ping Sun, and Steven A. Narod
  JCO Mar 1 2008: 1093–1097. First published on Jan 14 2008; 10.1200/JCO.2007.12.6078. [Abstract] [Full Text] [PDF]  

Hematologic Malignancies Back

Phase I Trial of Nelarabine in Indolent Leukemias
  Varsha Gandhi, Constantine Tam, Susan O'Brien, Roxanne C. Jewell, Carlos O. Rodriguez, Jr, Susan Lerner, William Plunkett, and Michael J. Keating
  JCO Mar 1 2008: 1098–1105. [Abstract] [Full Text] [PDF]  

Pediatric Oncology Back

Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane
  Elly V. Barry, Lynda M. Vrooman, Suzanne E. Dahlberg, Donna S. Neuberg, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Eric C. Larsen, Albert Moghrabi, Yvan Samson, Marshall A. Schorin, Harvey J. Cohen, Steven E. Lipshultz, Stephen E. Sallan, and Lewis B. Silverman
  JCO Mar 1 2008: 1106–1111. [Abstract] [Full Text] [PDF]  
Endocrine Outcomes for Children With Embryonal Brain Tumors After Risk-Adapted Craniospinal and Conformal Primary-Site Irradiation and High-Dose Chemotherapy With Stem-Cell Rescue on the SJMB-96 Trial
  Stephen J. Laughton, Thomas E. Merchant, Charles A. Sklar, Larry E. Kun, Maryam Fouladi, Alberto Broniscer, E. Brannon Morris, Robert P. Sanders, Matthew J. Krasin, John Shelso, Zang Xiong, Dana Wallace, and Amar Gajjar
  JCO Mar 1 2008: 1112–1118. [Abstract] [Full Text] [PDF]  

Phase I and Clinical Pharmacology Back

Pharmacogenomic and Pharmacokinetic Determinants of Erlotinib Toxicity
  Charles M. Rudin, Wanqing Liu, Apurva Desai, Theodore Karrison, Xuemin Jiang, Linda Janisch, Soma Das, Jacqueline Ramirez, Balasubramanian Poonkuzhali, Erin Schuetz, Donna Lee Fackenthal, Peixian Chen, Deborah K. Armstrong, Julie R. Brahmer, Gini F. Fleming, Everett E. Vokes, Michael A. Carducci, and Mark J. Ratain
  JCO Mar 1 2008: 1119–1127. [Abstract] [Full Text] [PDF]  

Thoracic Oncology Back

Prognostic Stratification of Stage IIIA-N2 Non–Small-Cell Lung Cancer After Induction Chemotherapy: A Model Based on the Combination of Morphometric-Pathologic Response in Mediastinal Nodes and Primary Tumor Response on Serial 18-Fluoro-2-Deoxy-Glucose Positron Emission Tomography
  Christophe Dooms, Eric Verbeken, Sigrid Stroobants, Kris Nackaerts, Paul De Leyn, and Johan Vansteenkiste
  JCO Mar 1 2008: 1128–1134. [Abstract] [Full Text] [PDF]  
Enzastaurin, an Oral Serine/Threonine Kinase Inhibitor, As Second- or Third-Line Therapy of Non–Small-Cell Lung Cancer
  Yun Oh, Roy S. Herbst, Howard Burris, Ann Cleverly, Luna Musib, Michael Lahn, and Gerold Bepler
  JCO Mar 1 2008: 1135–1141. [Abstract] [Full Text] [PDF] [Chinese PDF]  
 
REVIEW ARTICLE Back
Outcomes of Adrenalectomy for Isolated Synchronous Versus Metachronous Adrenal Metastases in Non–Small-Cell Lung Cancer: A Systematic Review and Pooled Analysis
  Tawee Tanvetyanon, Lary A. Robinson, Michael J. Schell, Vivian E. Strong, Rachna Kapoor, Daniel G. Coit, and Gerold Bepler
  JCO Mar 1 2008: 1142–1147. [Abstract] [Full Text] [PDF]  
 
SPECIAL ARTICLES Back
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
  Howard I. Scher, Susan Halabi, Ian Tannock, Michael Morris, Cora N. Sternberg, Michael A. Carducci, Mario A. Eisenberger, Celestia Higano, Glenn J. Bubley, Robert Dreicer, Daniel Petrylak, Philip Kantoff, Ethan Basch, William Kevin Kelly, William D. Figg, Eric J. Small, Tomasz M. Beer, George Wilding, Alison Martin, and Maha Hussain
  JCO Mar 1 2008: 1148–1159. [Abstract] [Full Text] [PDF]  
Globalization of the Radiation Therapy Oncology Group: Implementation of a Model for Service Expansion and Public Health Improvement
  Benjamin W. Corn, Isaiah D. Wexler, Mohan Suntharalingam, Moshe Inbar, and Walter J. Curran, Jr
  JCO Mar 1 2008: 1160–1166. [Abstract] [Full Text] [PDF]  
 
DIAGNOSIS IN ONCOLOGY Back
Bilateral Panocular Involvement With Mantle-Cell Lymphoma
Aimee V. Chappelow, Arun D. Singh, Victor L. Perez, Alan Lichtin, Brad Pohlman, and Roger Macklis
JCO Mar 1 2008: 1167. [Full Text] [PDF]  
Small-Cell Carcinoma of the Prostate
Christopher J. Anker, Christopher Dechet, Jorge C. Isaac, Wallace Akerley, and Dennis C. Shrieve
JCO Mar 1 2008: 1168–1171. [Full Text] [PDF]  
Lung Cancer Presenting With Amegakaryocytic Thrombocytopenia
Wesley H. Witteles, Stanley L. Schrier, and Heather A. Wakelee
JCO Mar 1 2008: 1171–1174. [Full Text] [PDF]  
 
ART OF ONCOLOGY Back
Concealment of Information in Clinical Practice: Is Lying Less Stressful Than Telling the Truth?
Efharis Panagopoulou, Gesthimani Mintziori, Anthony Montgomery, Dorothea Kapoukranidou, and Alexis Benos
JCO Mar 1 2008: 1175–1177. [Full Text] [PDF]  
 
CORRESPONDENCE Back
Second-Line Therapy in Gemcitabine-Pretreated Patients With Advanced Pancreatic Cancer
Stefan Boeck and Volker Heinemann
JCO Mar 1 2008: 1178–1179. [Full Text] [PDF]  
In Reply
Matthew H. Kulke and Charles S. Fuchs
JCO Mar 1 2008: 1179. [Full Text] [PDF]  
Time-Dependent Prognostic Scoring System for Myelodysplastic Syndromes Has Significant Limitations That May Influence Its Reproducibility and Practical Application
David T. Bowen, Pierre Fenaux, Eva Hellstrom-Lindberg, and Theo de Witte
JCO Mar 1 2008: 1180. [Full Text] [PDF]  
In Reply
Luca Malcovati, Mario Cazzola, and Ulrich Germing
JCO Mar 1 2008: 1181–1182. [Full Text] [PDF]  
Differential Responses to Erlotinib in Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Cancers With Acquired Resistance to Gefitinib Carrying the L747S or T790M Secondary Mutations
Daniel B. Costa, Susan T. Schumer, Daniel G. Tenen, and Susumu Kobayashi
JCO Mar 1 2008: 1182–1184. [Full Text] [PDF]  
In Reply
Byoung Chul Cho and Joo Hang Kim
JCO Mar 1 2008: 1184–1186. [Full Text] [PDF]  
Run Batch Effects Potentially Compromise the Usefulness of Genomic Signatures for Ovarian Cancer
Keith A. Baggerly, Kevin R. Coombes, and E. Shannon Neeley
JCO Mar 1 2008: 1186–1187. [Full Text] [PDF] [Data Supplements]  
In Reply
Holly K. Dressman, Anil Potti, Joseph R. Nevins, and Johnathan M. Lancaster
JCO Mar 1 2008: 1187–1188. [Full Text] [PDF]  
Oxaliplatin-Related Neurotoxicity: Interest of Calcium-Magnesium Infusion and No Impact on Its Efficacy
Laurence Gamelin, Michèle Boisdron-Celle, Alain Morel, Anne Lise Poirier, Virginie Berger, Erick Gamelin, Christophe Tournigand, and Aimery de Gramont
JCO Mar 1 2008: 1188–1189. [Full Text] [PDF]  
In Reply
Howard S. Hochster and Axel Grothey
JCO Mar 1 2008: 1189. [Full Text] [PDF]  
Magnetic Resonance Imaging Versus Bone Scan in High-Risk Prostatic Carcinoma: Some Methodological Considerations
Filip F.A.Y. Gemmel and Frank W. De Geeter
JCO Mar 1 2008: 1189–1190. [Full Text] [PDF]  
In Reply
Frédéric E. Lecouvet, Bruno C. Vande Berg, François Jamar, Bertrand Tombal, Jacques Jamart, and Bertrand Janne d'Othée
JCO Mar 1 2008: 1190–1191. [Full Text] [PDF]  
 
ERRATA Back
ERRATUM
JCO Mar 1 2008: 1192. [Full Text] [PDF]  
ERRATUM
JCO Mar 1 2008: 1192. [Full Text] [PDF]  


To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online